Several reports demonstrated that alterations in the composition of gut microbiota and their translocation to secondary lymphoid organs can stimulate immune responses against tumors by influencing various cell types such as CD8+ and CD4+ T cells as well as tumor-associated myeloid cells (20, 21). The gene discussed is CD4; the disease is neoplasm.